Clinical Trial Update: An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With Asthma [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial assessing correct and ease of use of the ELLIPTA dry powder inhaler in pediatric asthma patients; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ELLIPTA DPI

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2019-12-09